Diagnostic Biologique des Maladies Lysosomales, Annale de Biologie Clinique, vol.64, pp.592-600, 2006. ,
Pathogenic mechanisms in lysosomal disease: a reappraisal of the role of the lysosome, Acta Paediatrica, vol.1, pp.26-32, 2007. ,
DOI : 10.1111/j.1651-2227.2007.00202.x
Lysosomal storage disorders, British Journal of Haematology, vol.24, issue.Part 9, pp.413-444, 2005. ,
DOI : 10.1111/j.1365-2141.2004.05293.x
STUDIES ON MICROPEROXISOMES IV. INTERRELATIONS OF MICROPEROXISOMES, ENDOPLASMIC RETICULUM AND LIPOFUSCIN GRANULES, Journal of Histochemistry & Cytochemistry, vol.21, issue.11, pp.1010-1030, 1973. ,
DOI : 10.1177/21.11.1010
Disorders of Lysosome-Related Organelle Biogenesis: Clinical and Molecular Genetics, Annual Review of Genomics and Human Genetics, vol.9, issue.1, pp.359-86, 2008. ,
DOI : 10.1146/annurev.genom.9.081307.164303
The neuronal endosomal-lysosomal system in Alzheimer's disease, Journal of Alzheimer's Disease, vol.3, issue.1, pp.97-107, 2001. ,
DOI : 10.3233/JAD-2001-3114
Biochimie du lysosome: Place des cibles thérapeutiques, Annale de Biologie Clinique, vol.64, pp.590-592, 2006. ,
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function, Nature Reviews Molecular Cell Biology, vol.180, issue.9, pp.623-658, 2009. ,
DOI : 10.1083/jcb.200210166
Lysosome-endosome fusion and lysosome biogenesis, Journal of cell science, vol.113, pp.1515-1539, 2000. ,
signalling in health and disease, Biochemical Journal, vol.109, issue.3, pp.349-74, 2011. ,
DOI : 10.1073/pnas.93.19.10510
Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes, Cell, vol.106, issue.2, pp.157-69, 2001. ,
DOI : 10.1016/S0092-8674(01)00421-4
Lysosomal Function and Dysfunction: Mechanism and Disease, Antioxidants & Redox Signaling, vol.17, issue.5, pp.766-74, 2012. ,
DOI : 10.1089/ars.2011.4405
The endosome???lysosome pathway and information generation in the immune system, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, vol.1824, issue.1, pp.14-21, 2012. ,
DOI : 10.1016/j.bbapap.2011.07.006
Unesterified Cholesterol Accumulation in Late Endosomes/Lysosomes Causes Neurodegeneration and Is Prevented by Driving Cholesterol Export from This Compartment, Journal of Neuroscience, vol.31, issue.25, pp.9404-9417, 2011. ,
DOI : 10.1523/JNEUROSCI.1317-11.2011
Sorting of lysosomal proteins, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.605-619, 2009. ,
DOI : 10.1016/j.bbamcr.2008.10.016
Mannose 6-phosphate-independent targeting of lysosomal enzymes in I- cell disease B lymphoblasts, The Journal of Cell Biology, vol.123, issue.1, pp.99-108, 1993. ,
DOI : 10.1083/jcb.123.1.99
Liver sinusoidal endothelial cells depend on mannose receptor-mediated recruitment of lysosomal enzymes for normal degradation capacity, Hepatology, vol.306, issue.Pt 10, 2008. ,
DOI : 10.1002/hep.22527
The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin, The EMBO Journal, vol.19, issue.24, pp.6430-6437, 2003. ,
DOI : 10.1126/science.1060896
The Lysosomal Trafficking of Acid Sphingomyelinase is Mediated by Sortilin and Mannose 6-phosphate Receptor, Traffic, vol.922, issue.7, pp.889-902, 2006. ,
DOI : 10.1111/j.1600-0854.2006.00429.x
LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of ??-Glucocerebrosidase, Cell, vol.131, issue.4, pp.770-83, 2007. ,
DOI : 10.1016/j.cell.2007.10.018
At the acidic edge: emerging functions for lysosomal membrane proteins, Trends in Cell Biology, vol.13, issue.3, pp.137-182, 2003. ,
DOI : 10.1016/S0962-8924(03)00005-9
Les maladies lysosomales de lhomme et des animaux domestiques, Revue de Médecine Vétérinaire, vol.152, pp.435-481, 2001. ,
Animal model of human disease. Mannosidosis. Swainsonineinduced mannosidosis, American Journal Of Pathology, vol.107, pp.124-130, 1982. ,
Chloroquine-induced cytosomes with curvilinear profiles in muscle, Muscle & Nerve, vol.50, issue.5, pp.376-81, 1979. ,
DOI : 10.1002/mus.880020509
A Case of Chloroquine-Induced Cardiomyopathy That Presented as Sick Sinus Syndrome, Korean Circulation Journal, vol.40, issue.11, pp.604-612, 2010. ,
DOI : 10.4070/kcj.2010.40.11.604
Lysosomal Storage Disorders in the Newborn, PEDIATRICS, vol.123, issue.4, pp.1191-207, 2009. ,
DOI : 10.1542/peds.2008-0635
Lysosomal Storage Disease: Revealing Lysosomal Function and Physiology, Physiology, vol.25, issue.2, pp.102-117, 2010. ,
DOI : 10.1152/physiol.00041.2009
The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations, Journal of Inherited Metabolic Disease, vol.93, issue.2, pp.387-96, 2010. ,
DOI : 10.1007/s10545-010-9093-7
Lysosomal storage disorders: Molecular basis and laboratory testing, Human Genomics, vol.5, issue.3, pp.156-69, 2011. ,
DOI : 10.1136/jmg.2004.029744
Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care, The Journal of Pediatrics, vol.144, issue.5, pp.3-14, 2004. ,
DOI : 10.1016/j.jpeds.2004.01.049
Lysosomal disorders: From storage to cellular damage, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.684-96, 2009. ,
DOI : 10.1016/j.bbamcr.2008.12.001
Molecular and cellular basis of lysosomal transmembrane protein dysfunction, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.636-685, 2009. ,
DOI : 10.1016/j.bbamcr.2008.12.008
URL : https://hal.archives-ouvertes.fr/hal-00415318
Molecular basis of multiple sulfatase deficiency, mucolipidosis II/III and Niemann???Pick C1 disease ??? Lysosomal storage disorders caused by defects of non-lysosomal proteins, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.710-735, 2009. ,
DOI : 10.1016/j.bbamcr.2008.11.015
The role of saposin C in Gaucher disease, Molecular Genetics and Metabolism, vol.106, issue.3, pp.257-63, 2012. ,
DOI : 10.1016/j.ymgme.2012.04.024
Association of autophagy with cholesterol-accumulated compartments in Niemann-Pick disease type C cells, Journal of Clinical Neuroscience, vol.16, issue.7, pp.954-963, 2009. ,
DOI : 10.1016/j.jocn.2008.09.020
Pathogenic cascades in lysosomal disease-Why so complex, Journal of inherited metabolic disease, vol.32, pp.181-190, 2009. ,
Clarifying lysosomal storage diseases, Trends in Neurosciences, vol.34, issue.8, pp.401-411, 2011. ,
DOI : 10.1016/j.tins.2011.05.006
Common and Uncommon Pathogenic Cascades in Lysosomal Storage Diseases: TABLE 1, Journal of Biological Chemistry, vol.285, issue.27, pp.20423-20430, 2010. ,
DOI : 10.1074/jbc.R110.134452
Gaucher disease: pathological mechanisms and modern management, British Journal of Haematology, vol.41, issue.2, pp.178-88, 2005. ,
DOI : 10.1016/S0140-6736(89)90536-9
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis, Brain, vol.126, issue.4, pp.974-87, 2003. ,
DOI : 10.1093/brain/awg089
Beneficial effects of anti-inflammatory therapy in a mouse model of Niemann-Pick disease type C1, Neurobiology of Disease, vol.36, issue.2, pp.242-51, 2009. ,
DOI : 10.1016/j.nbd.2009.07.010
ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones, Human Molecular Genetics, vol.17, issue.4, pp.469-77, 2008. ,
DOI : 10.1093/hmg/ddm324
The cell biology of lysosomal storage disorders, Nature Reviews Molecular Cell Biology, vol.141, issue.7, pp.554-65, 2004. ,
DOI : 10.1073/pnas.0308456101
Treating lysosomal storage disorders: Current practice and future prospects, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1793, issue.4, pp.737-782, 2009. ,
DOI : 10.1016/j.bbamcr.2008.08.009
Lysosomal storage disorders$: commonalities and differences, Lysosomal storage diseases, pp.3-12, 2010. ,
Progrès dans les maladies lysosomales, Maladies métaboliques héréditaires. , Progrès en pédiatrie, pp.25-55, 2011. ,
Aspects cytologiques des maladies de surcharge lysosomale, Revue Fran??aise des Laboratoires, vol.1998, issue.303, pp.31-36, 1998. ,
DOI : 10.1016/S0338-9898(98)80064-4
Extracerebral Biopsy in Lysosomal and Peroxisomal Disorders, Ultrastructural Findings. brain pathology, vol.8, pp.121-153, 1998. ,
Mucopolysaccharidoses diagnostic approaches, 2012. ,
Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses, Clinical chemistry, vol.35, pp.1472-1479, 1989. ,
Quantitation of urinary glycosaminoglycans using dimethylene blue as a screening technique for the diagnosis of mucopolysaccharidoses ??? an evaluation, Annals of Clinical Biochemistry, vol.44, issue.4, pp.360-363, 2007. ,
DOI : 10.1258/000456307780945688
Heparan sulfate levels in mucopolysaccharidoses and mucolipidoses, Journal of Inherited Metabolic Disease, vol.177, issue.4, pp.743-57, 2005. ,
DOI : 10.1007/s10545-005-0069-y
Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI. Molecular genetics and metabolism, pp.49-56, 2011. ,
Disease-Specific Markers for the Mucopolysaccharidoses, Pediatric Research, vol.118, issue.5, pp.733-741, 2004. ,
DOI : 10.1203/01.PDR.0000141987.69757.DD
Validation of disaccharide compositions derived from dermatan sulfate and heparan sulfate in mucopolysaccharidoses and mucolipidoses II and III by tandem mass spectrometry, Molecular Genetics and Metabolism, vol.99, issue.2, pp.124-155, 2010. ,
DOI : 10.1016/j.ymgme.2009.10.001
Evaluation of reliability for urine mucopolysaccharidosis screening by dimethylmethylene blue and Berry spot tests, Clinica Chimica Acta, vol.345, issue.1-2, pp.135-175, 2004. ,
DOI : 10.1016/j.cccn.2004.03.015
36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy, Journal of Inherited Metabolic Disease, vol.104, issue.3, 2012. ,
DOI : 10.1007/s10545-012-9451-8
Plasma chitotriosidase activity in children with lysosomal storage disorders, The Indian Journal of Pediatrics, vol.273, issue.2, pp.203-208, 2010. ,
DOI : 10.1007/s12098-009-0249-0
Urinary glycosaminoglycan excretion in patients with primary nocturnal enuresis, Italian Journal of Pediatrics, vol.36, issue.1, p.13, 2010. ,
DOI : 10.1186/1824-7288-36-13
What can cell biology tell us about heterogeneity in lysosomal storage diseases?, Acta Paediatrica, vol.94, pp.80-86, 2005. ,
Pseudodeficiencies of lysosomal hydrolases, American journal of human genetics, vol.54, pp.934-974, 1994. ,
Pseudodeficiency of arylsulphatase A: Strategy for clarification of genotype in families of subjects with low ASA activity and neurological symptoms, Journal of Inherited Metabolic Disease, vol.52, issue.6, pp.710-716, 1995. ,
DOI : 10.1007/BF02436761
Diagnostic biologique et mol??culaire des maladies de surcharge lysosomale, Revue Fran??aise des Laboratoires, vol.1998, issue.303, pp.37-40, 1998. ,
DOI : 10.1016/S0338-9898(98)80065-6
The genotype-phenotype correlation in Pompe disease, American Journal of Medical Genetics Part C: Seminars in Medical Genetics, vol.19, issue.1, pp.59-68, 2012. ,
DOI : 10.1002/ajmg.c.31318
Can mucopolysaccharidosis type I disease severity be predicted based on a patient???s genotype? A comprehensive review of the literature, Genetics in Medicine, vol.11, issue.4, pp.286-94, 2003. ,
DOI : 10.1097/01.GIM.0000078027.83236.49
Tandem Mass Spectrometry for the Direct Assay of Lysosomal Enzymes in Dried Blood Spots: Application to Screening Newborns for Mucopolysaccharidosis I, Clinical Chemistry, vol.54, issue.12, pp.2067-70, 2010. ,
DOI : 10.1373/clinchem.2008.115410
Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: Application to a small-scale population study for five lysosomal storage disorders, Clinica Chimica Acta, vol.413, issue.15-16, pp.1270-1273, 2012. ,
DOI : 10.1016/j.cca.2012.04.012
First pilot newborn screening for four lysosomal storage diseases in an Italian region: Identification and analysis of a putative causative mutation in the GBA gene, Clinica Chimica Acta, vol.413, issue.23-24, pp.1827-1858, 2012. ,
DOI : 10.1016/j.cca.2012.07.011
The mucopolysaccharidoses., Journal of Medical Genetics, vol.13, issue.3, pp.169-81, 1976. ,
DOI : 10.1136/jmg.13.3.169
Hurler???s syndrome, The Indian Journal of Pediatrics, vol.33, issue.9, pp.301-307, 1965. ,
DOI : 10.1007/BF02756497
THE GENETIC MUCOPOLYSACCHARIDOSES, Medicine, vol.44, issue.6, pp.1-4, 1965. ,
DOI : 10.1097/00005792-196511000-00001
Human alpha-L-iduronidase: cDNA isolation and expression., Proceedings of the National Academy of Sciences, vol.88, issue.21, pp.9695-9704, 1991. ,
DOI : 10.1073/pnas.88.21.9695
Identification of Mutations in the a-L-lduronidase Gene ( IDUA ) That Cause Hurler and Scheie Syndromes, American journal of human genetics, vol.53, pp.973-86, 1993. ,
Enzyme replacement in a canine model of Hurler syndrome., Proceedings of the National Academy of Sciences, vol.91, issue.26, pp.12937-12978, 1994. ,
DOI : 10.1073/pnas.91.26.12937
Long-Term and High-Dose Trials of Enzyme Replacement Therapy in the Canine Model of Mucopolysaccharidosis I, Biochemical and Molecular Medicine, vol.58, issue.2, pp.156-67, 1996. ,
DOI : 10.1006/bmme.1996.0044
Enzyme replacement therapy in feline mucopolysaccharidosis I. Molecular genetics and metabolism, 2001. ,
Enzyme-Replacement Therapy in Mucopolysaccharidosis I, New England Journal of Medicine, vol.344, issue.3, pp.182-190, 2001. ,
DOI : 10.1056/NEJM200101183440304
Prévalence des maladies rares: Données bibliographiques, pp.1-30, 2012. ,
The livebirth prevalence of mucopolysaccharidoses in estonia, Protocole National De Diagnostic et De Soins, 2007. ,
Diagnosis and treatment trends in mucopolysaccharidosis I: findings from the MPS I Registry, European Journal of Pediatrics, vol.154, issue.859???864, pp.911-920, 2012. ,
DOI : 10.1007/s00431-011-1644-x
Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic, Archives of Disease in Childhood, vol.94, issue.1, pp.52-56, 2009. ,
DOI : 10.1136/adc.2007.135772
Mucopolysaccharidosis type I in 21 Czech and Slovak patients: Mutation analysis suggests a functional importance of C-terminus of the IDUA protein, American Journal of Medical Genetics Part A, vol.15, issue.5, pp.965-74, 2009. ,
DOI : 10.1002/ajmg.a.32812
Mucopolysaccharidoses in the Scandinavian countries: incidence and prevalence, Acta Paediatrica, vol.102, issue.11, pp.1577-81, 2008. ,
DOI : 10.1111/j.1651-2227.2008.00965.x
The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK, Orphanet Journal of Rare Diseases, vol.3, issue.1, p.24, 2008. ,
DOI : 10.1186/1750-1172-3-24
Spectrum of Paediatric Lysosomal Storage Disorders in Oman = ?????? ???????????????? ???????????????? ???? ???????????????? ???????????? ?????? ?????????????? ???? ????????, Sultan Qaboos University Medical Journal, vol.12, issue.3, pp.295-304, 2012. ,
DOI : 10.12816/0003142
Mucopolysaccharidosis I: Management and Treatment Guidelines, PEDIATRICS, vol.123, issue.1, pp.19-29, 2009. ,
DOI : 10.1542/peds.2008-0416
Guidelines for the Management of Mucopolysaccharidosis Type I, The Journal of Pediatrics, vol.155, issue.4, pp.32-46, 2009. ,
DOI : 10.1016/j.jpeds.2009.07.005
The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentations, The Journal of Pediatrics, vol.144, issue.5, pp.27-34, 2004. ,
DOI : 10.1016/j.jpeds.2004.01.052
Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management, Pediatric Anesthesia, vol.13, issue.8, pp.745-51, 2012. ,
DOI : 10.1111/j.1460-9592.2012.03897.x
Childhood onset of Scheie syndrome, the attenuated form of mucopolysaccharidosis I, Journal of Inherited Metabolic Disease, vol.144, issue.5, pp.421-428, 2010. ,
DOI : 10.1007/s10545-010-9113-7
High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I Registry, Journal of Pediatric Surgery, vol.47, issue.3, pp.477-84, 2012. ,
DOI : 10.1016/j.jpedsurg.2011.09.042
Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI, Journal of Inherited Metabolic Disease, vol.16, issue.2, 2012. ,
DOI : 10.1007/s10545-011-9444-z
Atlas of Metabolic Diseases, 2005. ,
Clinical Characteristics of MPS I Patients in the MPS I Registry. The American Society of, Human Genetics, 2007. ,
Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure, Orphanet Journal of Rare Diseases, vol.7, issue.1, p.22, 2012. ,
DOI : 10.1186/1750-1172-7-22
Characterization of Surgical Procedures in Patients with Mucopolysaccharidosis Type I: Findings from the MPS I Registry, The Journal of Pediatrics, vol.154, issue.6, pp.859-64, 2009. ,
DOI : 10.1016/j.jpeds.2008.12.024
Dried Blood Spot Analysis: An Easy and Reliable Tool to Monitor the Biochemical Effect of Hematopoietic Stem Cell Transplantation in Hurler Syndrome Patients, Biology of Blood and Marrow Transplantation, vol.16, issue.5, pp.701-705, 2010. ,
DOI : 10.1016/j.bbmt.2010.01.006
Molecular genetic defect underlying alpha-L-iduronidase pseudodeficiency, American journal of human genetics, vol.58, pp.75-85, 1996. ,
IDUA mutational profiling of a cohort of 102 European patients with mucopolysaccharidosis type I: identification and characterization of 35 novel ??-L-iduronidase (IDUA) alleles, Human Mutation, vol.32, issue.6, pp.2189-210, 2011. ,
DOI : 10.1002/humu.21479
URL : https://hal.archives-ouvertes.fr/hal-00621299
31. Genotype frequencies in the MPS I Registry, Molecular Genetics and Metabolism, vol.96, issue.2, p.19, 2009. ,
DOI : 10.1016/j.ymgme.2008.11.032
Molecular Genetics of Mucopolysaccharidosis Type I: Mutation Analysis among the Patients of the Former Soviet Union, Molecular Genetics and Metabolism, vol.65, issue.2, pp.174-80, 1998. ,
DOI : 10.1006/mgme.1998.2745
Mucopolysaccharidosis type I: characterization of a common mutation that causes Hurler syndrome in Moroccan subjects, Annals of Human Genetics, vol.63, issue.1, pp.9-16, 1999. ,
DOI : 10.1046/j.1469-1809.1999.6310009.x
Molecular analysis of mucopolysaccharidosis type I in Tunisia: identification of novel mutation and eight Novel polymorphisms, Diagnostic Pathology, vol.6, issue.1, p.39, 2011. ,
DOI : 10.1186/1746-1596-6-11
The ??-l-iduronidase mutations R89Q and R89W result in an attenuated mucopolysaccharidosis type I clinical presentation, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1639, issue.2, pp.95-103, 2003. ,
DOI : 10.1016/S0925-4439(03)00129-7
Genotype???phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1407, issue.3, pp.249-56, 1998. ,
DOI : 10.1016/S0925-4439(98)00046-5
Hurler Syndrome: II. Outcome of HLA-Genotypically Identical Sibling and HLA-Haploidentical Related Donor Bone Marrow Transplantation in Fifty-Four Children, Blood Cells, vol.91, pp.2601-2609, 1998. ,
Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis I, PEDIATRICS, vol.123, issue.1, pp.229-269, 2009. ,
DOI : 10.1542/peds.2007-3847
Enzyme Replacement Therapy in Patients Who Have Mucopolysaccharidosis I and Are Younger Than 5 Years: Results of a Multinational Study of Recombinant Human ??-L-Iduronidase (Laronidase), PEDIATRICS, vol.120, issue.1, pp.37-46, 2007. ,
DOI : 10.1542/peds.2006-2156
Specific antibody titer alters the effectiveness of intrathecal enzyme replacement therapy in canine mucopolysaccharidosis I. Molecular genetics and metabolism 2012, pp.68-72 ,
Replacing the Enzyme !-L-Iduronidase at Birth Ameliorates Symptoms in the Brain and Periphery of Dogs with Mucopolysaccharidosis Type I, Science Translational Medecine, vol.2, pp.1-18, 2011. ,
Cell microencapsulation: a potential tool for the treatment of neuronopathic lysosomal storage diseases, Journal of Inherited Metabolic Disease, vol.72, issue.2, pp.983-90, 2011. ,
DOI : 10.1007/s10545-011-9350-4
Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure, Orphanet journal of rare diseases, vol.6, p.55, 2011. ,
Therapy for the mucopolysaccharidoses, Rheumatology, vol.50, issue.suppl 5, pp.49-59, 2011. ,
DOI : 10.1093/rheumatology/ker396
Stop-codon read-through for patients affected by a lysosomal storage disorder, Trends in Molecular Medicine, vol.12, issue.8, pp.367-73, 2006. ,
DOI : 10.1016/j.molmed.2006.06.001
La mucopolysaccharidose de??type I: identification des??mutations du??g??ne alpha-L-iduronidase dans??des??familles tunisiennes, Archives de P??diatrie, vol.14, issue.10, pp.1183-1192, 2007. ,
DOI : 10.1016/j.arcped.2007.06.018
Mucopolysaccharidosis type I: molecular characteristics of two novel alpha-L-iduronidase mutations in Tunisian patients, Diagnostic Pathology, vol.6, issue.1, p.47, 2011. ,
DOI : 10.1186/1746-1596-6-11
Mucopolysaccharidosis I mutations in Chinese patients: identification of 27 novel mutations and 6 cases involving prenatal diagnosis, Clinical Genetics, vol.2, issue.8, pp.443-52, 2012. ,
DOI : 10.1111/j.1399-0004.2011.01680.x
The ocular features of the mucopolysaccharidoses, Eye, vol.96, issue.5, pp.553-63, 2006. ,
DOI : 10.1016/S0161-6420(98)96014-6
A dose-optimization trial of laronidase (Aldurazyme) in patients with mucopolysaccharidosis I. Molecular genetics and metabolism, pp.13-22, 2009. ,
Effect of rapid cessation of enzyme replacement therapy: A report of 5 cases and a review of the literature. Molecular genetics and metabolism 2012 ,
La maladie de Hurler: ?? propos de 30 cas, Revue Francophone des Laboratoires, vol.2011, issue.436, pp.73-79, 2011. ,
DOI : 10.1016/S1773-035X(11)71159-5
Analysis of cDNA Molecules is Not Suitable for the Molecular Diagnosis of Mucopolysaccharidosis Type I, Diagnostic Molecular Pathology, vol.21, issue.1, pp.53-58, 2012. ,
DOI : 10.1097/PDM.0b013e318230f021
Identification and characterization of 13 new mutations in mucopolysaccharidosis type I patients, Molecular Genetics and Metabolism, vol.78, issue.1, pp.37-43, 2003. ,
DOI : 10.1016/S1096-7192(02)00200-7
Alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype, Human mutation, vol.339, pp.333-342, 1992. ,
Mucopolysaccharidosis type I: Identification of common mutations that cause Hurler and Scheie syndromes in Japanese populations, Human Mutation, vol.95, issue.1, pp.23-32, 1996. ,
DOI : 10.1002/(SICI)1098-1004(1996)7:1<23::AID-HUMU3>3.0.CO;2-Q
Molecular analysis of 30 mucopolysaccharidosis type I patients: evaluation of the mutational spectrum in Italian population and identification of 13 novel mutations, Human Mutation, vol.20, issue.3, p.231, 2002. ,
DOI : 10.1002/humu.9051
Mutational analysis of 85 mucopolysaccharidosis type I families: frequency of known mutations, identification of 17 novel mutations and in vitro expression of missense mutations, Human genetics, vol.109, pp.503-514, 2001. ,
Diversity of mutations and distribution of single nucleotide polymorphic alleles in the human ??-l-iduronidase (IDUA) gene, Genetics in Medicine, vol.58, issue.6, pp.420-426, 2002. ,
DOI : 10.1097/00125817-200211000-00004